000 | 01636 a2200433 4500 | ||
---|---|---|---|
005 | 20250515121425.0 | ||
264 | 0 | _c20080911 | |
008 | 200809s 0 0 eng d | ||
022 | _a0271-0749 | ||
024 | 7 |
_a10.1097/JCP.0b013e318173083e _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFriedel, Robert O | |
245 | 0 | 0 |
_aRisperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study. _h[electronic resource] |
260 |
_bJournal of clinical psychopharmacology _cJun 2008 |
||
300 |
_a345-7 p. _bdigital |
||
500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
650 | 0 | 4 |
_aBorderline Personality Disorder _xdiagnosis |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aOutcome Assessment, Health Care _xstatistics & numerical data |
650 | 0 | 4 |
_aPersonality Inventory _xstatistics & numerical data |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 | _aPsychometrics |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 |
_aRisperidone _xadverse effects |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aWeight Gain _xdrug effects |
700 | 1 | _aJackson, Warren T | |
700 | 1 | _aHuston, Celia S | |
700 | 1 | _aMay, Roberta S | |
700 | 1 | _aKirby, Nancy L | |
700 | 1 | _aStoves, Andrée | |
773 | 0 |
_tJournal of clinical psychopharmacology _gvol. 28 _gno. 3 _gp. 345-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/JCP.0b013e318173083e _zAvailable from publisher's website |
999 |
_c17975374 _d17975374 |